Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 7, 2020; 26(41): 6488-6509
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6488
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6488
Figure 3 Network evidence of four endpoints.
A: Overall clinical efficacy; B: Irritable bowel syndrome symptom severity scale; C: Self-rating anxiety scale and self-rating depression scale; D: Adverse effects.
- Citation: Dai YK, Wu YB, Li RL, Chen WJ, Tang CZ, Lu LM, Hu L. Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome in adults. World J Gastroenterol 2020; 26(41): 6488-6509
- URL: https://www.wjgnet.com/1007-9327/full/v26/i41/6488.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i41.6488